Browsing byAuthorGreenfield, JR
Showing results 1 to 7 of 7
| Issue Date | Title | Author(s) |
| 2023-09 | Associations of Type 2 Diabetes, Body Composition, and Insulin Resistance with Bone Parameters: The Dubbo Osteoporosis Epidemiology Study. | Sheu, A; Blank, RD; Tran, T; Bliuc, D; Greenfield, JR; White, CP; Center, JR |
| 2022-12-20 | Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies-a joint review from endocrinologists and cardiologists. | Raven, LM; Muir, CA; Macdonald, PS; Hayward, CS; Jabbour, A; Greenfield, JR |
| 2019-05 | Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients. | Cehic, MG; Muir, CA; Greenfield, JR; Hayward, C; Jabbour, A; Keogh, A; Kotlyar, E; Muthiah, K; Macdonald, PS |
| 2023-09 | Metabolic Sequelae of Everolimus Treatment After Cardiac Transplant: A Hypothesis-Generating Study. | Raven, LM; Muir, CA; Pouliopoulos, J; Hayward, CS; Macdonald, PS; Greenfield, JR; Jabbour, A |
| 2023-11-15 | Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices. | Chavali, S; Barua, S; Adji, A; Robson, D; Raven, LM; Greenfield, JR; Eckford, H; Macdonald, PS; Hayward, CS; Muthiah, K |
| 2023-03-29 | Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a randomised controlled trial. | Raven, LM; Muir, CA; Kessler Iglesias, C; Bart, NK; Muthiah, K; Kotlyar, E; Macdonald, P; Hayward, CS; Jabbour, A; Greenfield, JR |
| 2023-08 | The safe use of metformin in heart failure patients both with and without T2DM: A cross-sectional and longitudinal study. | Chowdhury, G; Carland, JE; Kumar, S; Olsen, N; Graham, G; Kumarasinghe, G; Hayward, CS; Greenfield, JR; Macdonald, P; Day, RO; Stocker, SL |
